Commercialisation TIMELINE

STAGE ONE                                                                 TIME

Design and fabrication of 5 CE-marked production models and headset                 2022/23

Demonstrate to research institutes and pharma companies.                                    2023/23

Health Economic and Clinical integration Studies                                                      2022

On-going R&D (Alzheimer’s; PCS; Anxiety, PTSD                                               2022- 24

STAGE TWO

Strategy and plan for TGA/FDA Regulatory approval and MBS registration              2022

Negotiate licenses with Pharma and Research Institutions.                                      2022/23

Commence 3 Clinical trials for TGA/FDA Regulatory approval.                                  2023

On-going Product Development (hardware miniaturisation & AI Software) Ongoing

STAGE THREE

Complete trials and obtain TGA (Australia) registration                                          2023/24

FDA Registration                                                                                                    2023/24

STAGE FOUR

License to a major medical device manufacturer and distributor.                             2024/25

Negotiate MBS Medicare item numbers.                                                                 2024/25

Promotion to Clinicians Australia; USA; Europe.                                                    2025/26